🇺🇸 FDA
Patent

US 8193211

Controlled release compositions of gamma-hydroxybutyrate

granted A61KA61K31/19A61K9/1635

Quick answer

US patent 8193211 (Controlled release compositions of gamma-hydroxybutyrate) held by Supernus Pharmaceuticals, Inc. expires Mon May 31 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Supernus Pharmaceuticals, Inc.
Grant date
Tue Jun 05 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 31 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
30
CPC classes
A61K, A61K31/19, A61K9/1635, A61K9/1652, A61K9/5026